Publication

Transmission and spreading of tauopathy in transgenic mouse brain

About
Privacy
Disclaimer

Graph Chatbot

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Transmission and spreading of tauopathy in transgenic mouse brain

Graph Chatbot

Chat with Graph Search

Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer's disease pathology and clinical disease progression

Rethinking protein aggregation and drug discovery in neurodegenerative diseases: Why we need to embrace complexity?

Pharmacological characterization of mutant huntingtin aggregate-directed PET imaging tracer candidates

Discovery of 2-(4-(2-fluoroethoxy)piperidin-1-yl)-9-methyl-9H-pyrrolo[2,3-b:4,5-c']dipyridine ([18F]PI-2014) as PET tracer for the detection of pathological aggregated tau in Alzheimer's disease and other tauopathies

Anti-Aβ antibodies bound to neuritic plaques enhance microglia activity and mitigate tau pathology

Phosphorylation of the overlooked tyrosine 310 regulates the structure, aggregation, and microtubule- and lipid-binding properties of Tau

Application of anti-amyloid beta immunization using encapsulated cell technology in mouse models of Alzheimer's disease

A viral vector based in vivo model of tauopathy to explore therapeutic strategies against tau pathology

Phospho-S129 Alpha-Synuclein Is Present in Human Plasma but Not in Cerebrospinal Fluid as Determined by an Ultrasensitive Immunoassay

Calpain-mediated tau fragmentation is altered in Alzheimer's disease progression